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Abstract 
Aim: Inhalant abuse in the adolescent population is a growing concern for care givers, communities, 
physicians and medical providers. The aim of this article is to provide a review of the literature about this 
new challenge. In addition, it raises awareness about recent health policy rulings. Methods: Review of the 
literature was done. 
Results: In this review article, the prevalence of different modes of inhalant use and abuse in children and 
young adults and their potential health implications will be examined: Cigarettes, ENDS (E Cigarettes), 
Hookah, Marijuana and Huffing. Additionally, marketing and advertising tactics will be reviewed to 
understand how they target this population. A review of current health policy recommendations from the 
FDA, American Thoracic Society and the American Academy of Pediatrics will also be discussed.  
Conclusion: The rapid rise in e-cigarette and hookah use in school aged children should trigger a call to 
action in the medical and public health communities. Health policy recommendations need to be made to 







Inhalant abuse in the adolescent population is a growing concern for care givers, communities, physicians 
and medical providers alike. Aside from the health implications, addiction to certain inhalant substances 
most often begins in adolescents (1). As one of public health’s greatest successes, tobacco control has 
helped mitigate the prevalence of smoking, and many of the adverse health effects associated with it. With 
the development and introduction of new devices like the electronic cigarettes (e-cigarettes or electronic 
nicotine delivery system (ENDS)) and hookah, it has become more difficult to monitor and regulate the use 
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(e-cigarettes) is growing rapidly among American youth and young adults. Although the health 
implications of some substances, like cigarette and alcohol remain clear, we have yet to understand the risk 
of others (2). However, while smoking is not as socially-acceptable as it was several years ago, now, much 
more work in advocacy and increasing awareness needs to be done to address the new devices and other 
inhalants. Along with traditional cigarette smoking, the increased use of alternative forms of tobacco, such 
as hookah (water-pipes) and e-cigarettes, has led to the development of new research efforts documenting 
both prevalence of smoking and the health consequences associated with their usage. Marketing campaigns 
take aim at the youth with their unique colors, designs, and popularity during this social media era. The 
lack of regulations on the advertisement of these products may lead to increased prevalence of their use 
(3). Therefore, specific health policy recommendations need to be made to reduce the level of adolescent 
substance abuse (4). 
 
 
I. Category of Inhalants 
 
A.  Electronic Cigarettes (E-cigarettes) 
The idea of e-cigarette, a battery-powered nicotine delivery device dates back to 1963 but did not come to 
fruition until the e-cigarette was created in China by Hon Lik in 2003. The concept underlying the device 
was to deliver nicotine in a breathable form to provide characteristics of conventional tobacco but with the 
hope of reducing tobacco-associated diseases. E-cigarettes contain nicotine, propylene glycol, and 
vegetable glycerin in various combinations and are marketed with various flavors/additives to target 
various demographic groups (1,2,3,5). Driven by worldwide recognition of the inherent dangers associated 
with smoking and other tobacco product use, and aggressive marketing, the e-cigarette manufacturing has 
grown rapidly. Although touted as “safer” because of the lack of tar and other combustion products, they 
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e-cigarette delivery mechanisms (6). E-cigarettes are one of the world’s fastest growing products and have 
overtaken traditional cigarette use among school children as reported in a recent United States government 
survey (1). More than 80% of users felt that they were less harmful than combustible cigarettes and three-
fourths of individuals started them to reduce smoking or avoid relapsing. Smokers or former smokers often 
began e-cigarettes to deal with nicotine craving or withdrawal symptoms. Others stated that they used them 
because they were cheaper than smoking tobacco cigarettes (57%) or could be used in situations where 
smoking was prohibited (39%) (7,8). In 2015, a total of 25.3% of high school students reported current use 
of a tobacco product, including 13.0% who reported current use of ≥2 tobacco products. Among all high 
school students, e-cigarettes (16.0%) were the most common tobacco products used, followed by cigarettes 
(9.3%), cigars (8.6%), hookahs (7.2%), smokeless tobacco (6.0%), pipe tobacco (1.0%), and bidis (0.6%) 
(1) (Figure 1). Current use of any tobacco and ≥2 tobacco products among middle school students was 
7.4% and 3.3%, respectively. E-cigarettes (5.3%) were the tobacco product used most commonly by 
middle school students, followed by cigarettes (2.3%), hookahs (2.0%), smokeless tobacco (1.8%), cigars 
(1.6%), pipe tobacco (0.4%) and bidis (0.2%) (1) (Figure 2). 
There is scarce evidence about passive exposure to the vapor released or exhaled from e-cigarettes under 
real conditions. A study was conducted to characterize passive exposure to nicotine from e-cigarettes' 
vapor and conventional cigarettes' smoke at home among non-smokers under real-use conditions (9). The 
airborne markers were statistically higher in conventional cigarette homes than in e-cigarettes homes (5.7 
times higher). However, concentrations of both biomarkers (cotinine in saliva and urine) among non-
smokers exposed to conventional cigarettes and e-cigarettes’ vapor were statistically similar (only 2 and 
1.4 times higher, respectively). The levels of airborne nicotine and cotinine concentrations (both in saliva 
and urine) at the homes with e-cigarette users were significantly higher than at control homes (p < 0.001). 
The results show that non-smokers passively exposed to e-cigarettes absorb nicotine (9). 
As a relatively new and emerging nonconventional tobacco product, e-cigarettes have raised concerns due 
to limited data regarding long-term effects, the increased use among youth, a lack of government control 









This article is protected by copyright. All rights reserved. 
related toxic substances found in cigarette smoke, e-cigarette aerosols can cause upper respiratory tract 
irritation, dry cough, and dryness of the mucus membrane (10). One study also found that five minutes of 
e-cigarette use was associated with an immediate decrease in fraction of exhaled nitric oxide (FeNO) 
within the experimental group by 2.14 ppb (P= .005) but not in the control group (P= .859). Total 
respiratory impedance at 5 Hz in the experimental group was found to increase by 0.033 kPa/(L/s) 
(P= .001), and flow respiratory resistance at 5 Hz, 10 Hz, and 20 Hz and overall peripheral resistance were 
also statistically increased (P= .024), after using an e-cigarette. (11). In considering its cardiovascular 
effects, e-cigarettes are associated with increased systolic and diastolic blood pressures and heart rate (12). 
In another experimental study, it was found that the nicotine concentrations of e-cigarette solutions vary by 
manufacturer, indicating a need for better regulation and labelling (13). Aside from the harmful effects of 
nicotine, propylene glycol, the nicotine solvent used in e-cigarettes, has been shown to irritate the eye and 
respiratory system (12, 14). E-cigarette aerosol also contains toxic chemicals such as formaldehyde and 
acetaldehyde, though these levels are lower than those found in conventional cigarettes (15). 
In another study it was found that 39 out of 51 types of flavored e-cigarettes were found to contain a 
flavoring chemical known as diacetyl (16). Diacetyl received much attention a few years ago when eight 
people who had previously worked at a microwave popcorn-processing plant were found to have severe 
bronchiolitis obliterans. Upon further investigation by the National Institute of Occupational Safety and 
Health (NIOSH), it was determined that there was a strong association between this lung disease and 
airborne exposure to butter-flavoring chemicals in the facility, with diacetyl being the most prominent. 
Due to its occurrence in microwave popcorn manufacturing plants, bronchiolitis obliterans has become 
known as “popcorn lung.” (16). 
To protect young people from initiating or continuing the use of e-cigarettes, actions must be 
taken at the federal, state, and local levels. At the federal level, the U.S. Food and Drug Administration 
(FDA)—under authority granted to it by Congress under the Family Smoking Prevention and Tobacco 
Control Act of 2009—took a historic step to protect America’s youth from the harmful effects of using 
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of e-cigarettes. Through such action, FDA now requires minimum age restrictions to prevent sales 
to minors and prohibits sales through vending machines (in any facility that admits youth), and will 
require products to carry a nicotine warning (17). Unfortunately, language banning the sale of flavored e-
cigarette products was removed from the final version of the rule. In May 2016, the FDA published a 
Deeming Rule to extend its tobacco regulating authority to currently marketed products such as certain 
dissolvables, gels, hookah tobacco, electronic cigarettes, cigars, and pipe tobacco. Components and parts 
of tobacco products, but not their related accessories, are included in the scope of this proposed rule (4). 
B. Hookahs (water-pipe) 
 
Though hookah, or water-pipe smoking (WPS) has been in use for centuries, it is only recently that is has 
gained increased worldwide popularity (17,18). The prevalence of hookah tobacco smoking has increased 
worldwide, in part, because of misconceptions that it is safer (19). Hookah (WPS) has become popular 
among youth and young adults owing to its social acceptance, novelty, availability in numerous appealing 
flavors, and its relative low cost (18,20). Although both the chronic and the acute health consequences of 
hookah are beginning to surface in the literature, information about the negative short-term and long-term 
health effects is not being conveyed adequately to the general population; rather, health-related 
information is overshadowed by hookah bar marketing efforts and lack of regulatory involvement of 
governmental bodies (20). A systematic review using the approach of the Cochrane Collaboration was 
performed (comparing 6 cross-sectional studies) to systematically review the effects of WPS on lung 
function. The secondary objective was to compare the effects of WPS and cigarette smoking on lung 
function (21). Compared with no smoking, WPS was associated with a statistically significant standardized 
mean difference (SMD) in FEV1 (95% CI, -0.58 to -0.29; equivalent to a 4.04% lower FEV1 % predicted 
value). Comparing WPS with cigarette smoking, there was no statistically significant difference in FEV1, 
FVC, and FEV1 / FVC (21). In another cross-sectional study the effects of WPS on lung functions and 
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FEV1, FEV1/FVC Ratio, FEF-25%, FEF-50%, FEF-75% and FEF-75-85% were found among hookah 
smokers relative to their control group. There was also a significant reduction in FeNO among hookah 
smokers compared to control group (22). 
 
Hookah use amongst adolescents has been increasing over the past few years in the US and worldwide. 
According to the CDC’s analysis of the 2011–2015 National Youth Tobacco Survey, hookah usage was 
the third most common source of inhalant abuse amongst students in 2015 (1). The study found a non-
linear statistically significant increase noted between the years of 2011-2014 with a change from 4.1% to 
9.4% amongst high school students, dropping to 7.2% of high school students having one or more sessions 
of hookah within the past 30 days in 2015 (1). The biggest increase was found between the years of 2013-
2014. Prevalence nearly doubled for high school with a change of 5.2% (770,000) to 9.4% (1.3 million) 
(1). Prevalence amongst middle school students more than doubled from 1.1% (120,000) to 2.5% 
(280,000) (1). Similar international studies found much higher levels amongst adolescents. Based on the 
Global Youth Tobacco Survey that was conducted between 1999 and 2007, and involved more than 90,000 
children (13–15 years) in the Eastern Mediterranean Region, the prevalence of WPS has become higher 
than cigarette smoking among youth in this region (23).  
While research about hookah smoking is still emerging, current findings show that it poses many 
problems. Hookah has been found to be significantly associated with lung cancer (24), communicable 
diseases such as hepatitis C (25), tuberculosis (26), respiratory illness (defined as perennial rhinitis and 
including nasal congestion and wheezing), periodontal disease (27). Other acute respiratory effects of WPS 
included increased respiratory rate (RR), carbon monoxide (CO), and carboxyhemoglobin (COHb) (28,29). 
Chronically, WPS has been associated COPD, chronic bronchitis, emphysema, and asthma (27). Some 
proposed mechanisms of WPS-induced respiratory effect include CO exposure, increased airway 
resistance, lung inflammation, oxidative stress, and damage to the airway ciliary epithelium (21, 30, 31).  
In another study which looked at the acute effects of WPS on the cardiovascular system, it was found that 
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(p<0.001), heart rate (p<0.001), and carbon monoxide levels (p<0.001) (32). Over long-term use, WPS has 
also been associated with an increased odds of coronary artery disease (CAD) in comparison to individuals 
who never smoked (28, 29). Mechanisms that have been proposed to explain the association of WPS with 
cardiovascular issues include endothelial dysfunction, HR variability, and increased oxidative stress (8). 
Aside from this, WPS has been associated with a risk for contracting communicable diseases, as the water 
pipe and water inside can harbor bacteria (25, 26, 31). 
Another study, examined the effect of smoking on three groups of pregnant women: those who smoked 
hookah during pregnancy, those who smoked cigarettes during this time, and a third group which did not 
smoke at all. It was found that the children born to women who smoked hookah weighed about 100 grams 
less than the children born to non-smokers (p<0.1), and that this finding was less significant than cigarette 
smoking (33). It was also found that the adjusted risk of having pulmonary problems, malformations (such 
as hydrocephalus), and perinatal complications increased among babies that were born to hookah and 
cigarette users. The risk was highest among hookah users, however, with an odds ratio of 3.65 (95% CI 
1.52-8.75) (33). Furthermore, while studies have determined several adverse health effects associated with 
WPS, one particular study analyzed the air quality of 10 WPS bars. It was found that all had an unhealthy 
air quality index (AQI) of 151-200, while two were found to reach a dangerous AQI level of 301-500 (31). 
 
C. Cigarettes  
The epidemic of smoking- caused disease in the twentieth century ranks among the greatest public health 
catastrophes of the century. The decline of smoking consequent to tobacco control is surely one of public 
health’s greatest successes. However, the current rate of progress in tobacco control is not fast enough and 
much more needs to be done to end the tobacco epidemic (34). Tobacco use and addiction most often 
begin during youth and young adulthood (34, 35). From the current literature, cigarette smoking harms 
almost every organ in the body. It was reported that 71% of people in the United States that smoke tried 
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developing brain (34). This leads to much concern over the health implications of tobacco exposure in at 
risk adolescent and youth populations. 
The effect of tobacco exposure on adolescent lung development has been found to create significant health 
implications. Cigarette smoking is associated with evidence of mild airway obstruction and slowed growth 
of lung function in adolescents. Adolescent girls may be more vulnerable than boys to the effects of 
smoking on the growth of their lung function (36). Furthermore, given that allergens and environmental 
pollutants have long been known to cause or exacerbate asthma, there is accumulating evidence linking 
cigarette smoking to asthma. In a large population-based sample of young teenagers, it was reported that 
asthma and allergic diseases were significantly associated with active tobacco smoking even after 
controlling for passive tobacco smoking exposure, which is known to increase asthma in children (37). In 
another study conducted on middle school children, children who currently smoked or reported any 
tobacco smoke exposure were at an increased risk of reporting active asthma symptoms (38). This work 
suggests that active cigarette smoking could be a risk factor for asthma amongst adolescents as well. Both 
allergic rhinitis and eczema are more commonly reported by current smokers among adolescents and by 
former smokers among adults, respectively (37). The association between smoking and idiopathic 
pulmonary fibrosis (IPF) has also been investigated. In a case-control study involved subjects diagnosed 
with IPF, a history of smoking was associated with an increased risk of developing IPF (39). 
 
In addition, psychiatric comorbidity is common in adolescent cigarette smokers, especially disruptive 
behavior disorders (such as oppositional defiant disorder, conduct disorder, and attention-
deficit/hyperactivity disorder), major depressive disorders, and drug and alcohol use disorders (40). 
Anxiety disorders are modestly associated with cigarette smoking. Both early onset (<13 years) cigarette 
smoking and conduct problems seem to be robust markers of increased psychopathology, including 
substance abuse, later in life. In spite of the high comorbidity, very few adolescents have nicotine 
dependence diagnosed or receive smoking cessation treatment in child and adolescent psychiatric 
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D. Other Inhalant (Marijuana) 
Marijuana (cannabis) is the most commonly used illicit drug in the United States. It is also the most 
widely used illicit drug on college campuses (41). Moreover, its use is increasing among adolescents and 
young adults, partially due to society’s changing beliefs about cannabis use and its legal status (42). As of 
February 2015, 23 states and the District of Columbia have implemented medical marijuana laws (MMLs), 
which permit marijuana use for medical purposes. Despite the growing consensus about the relief medical 
marijuana can bring for a range of serious illnesses, concerns have been voiced that MMLs may give rise 
to increased marijuana use in the general population and increased use of other substances (43). A study 
examined the effect of the implementation of MMLs in ten states between 2004 and 2012 on a variety of 
substance use outcomes including marijuana use, alcohol use, pain medication misuse, and hard drug use 
in both adolescent and adult populations (43). It was concluded that implementation of an MML led to a 
relative 14 percent increase in the probability of past-month marijuana use and a 15 percent increase in the 
probability of almost daily/daily marijuana use among adults aged 21 or above. For this age group, MML 
implementation also resulted in a 10 percent increase in the probability of marijuana abuse/dependence 
(43). Among adolescents and young adults aged 12–20, it was found that a 5 percent increase in the 
probability of past-year marijuana use initiation was attributable to MML implementation (43).  
 
E. Huffing 
Inhalant use is the deliberate inhalation of volatile substances, via sniffing, snorting, bagging, or huffing, to 
induce a psychoactive or mind-altering effect. It is a serious drug problem worldwide, particularly in 
disadvantaged populations and among adolescents (44). Inhalant abuse is a significant problem affecting 
many people, particularly youth. The easy availability of products containing volatile substances (e.g., 
aerosol sprays, cleaning products, paint) provides opportunity for mind-altering experiences. 
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may ensue (45). Adolescents perceive the risk as low, and parents may be unaware of the risks. Health care 
providers, particularly psychiatrists, should undertake strategies of prevention, assessment, and treatment  
of this challenging problem (46). 
Inhalant abuse and dependence among adolescents in the United States age 12-17 years was  
 0.2% and 0.2% respectively. The prevalence of inhalant abuse and dependence among one year inhalant 
users was 6% and 4%, respectively (44). The most commonly used inhalants were glue/shoe polish and 
gasoline, which were used by 43% and 36%, respectively, of inhalant users. About one-half (51%) of 
adolescent inhalant users had used two or more types of inhalants in their lifetime. Most (80%) inhalant 
users reported their first inhalant use before age 15. Males were more likely to have ever used gasoline and 
nitrous oxide, whereas females were more likely to have ever used glue/shoe polish, spray paints, 
correction fluid, and aerosol sprays (44). According to data from the 2000/2001 National Household 
Survey on Drug Abuse, approximately 9.0% of U.S. 12- to 17-year-olds had used inhalants and, of these, 
21.7% reported lifetime nitrous oxide (NO) use, making NO use the fourth most prevalent specific class of 
inhalants used nationally among adolescents, with a lifetime prevalence of use estimated at 2.0% (44). 
Few studies have examined the prevalence of NO inhalation or co-occurrence of NO and volatile solvent 
(VS) use in adolescents. A study was done with the aim of describing the independent and conjoint 
prevalence of NO and VS use in incarcerated youth, who were ethnically diverse and predominantly male 
(47). Lifetime prevalence of NO use was 15.8%. NO and VS users demonstrated greater impairments 
compared to NO and VS nonusers. VS-only users demonstrated impairments that were similar in kind but 
at lower prevalence compared to those displayed by NO and VS users, whereas NO-only youth had 
profiles that were similar to those of NO/VS nonusers. Psychiatric disorders, polydrug use, and 
temperamental fearlessness were correlates of NO use. NO and VS users were at high risk for behavioral 
and emotional problems. Screening and interventions for NO and VS inhalant use should be implemented 
in juvenile justice facilities (47).  
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Whereas risk taking during the teenage years may be normative and functionally adaptive as the adolescent 
strives for independence from adults, such behaviors may also contribute to an incentive to initiate drug 
use. Given the unique neurodevelopmental processes taking place during adolescence, trying out new 
experiences and taking risks (including drug use) is more likely among teenagers than among children and 
adults (48). The emerging science of neuro-development is providing a new framework for viewing 
adolescent risk-taking, including decisions made by young people to use tobacco and/or other drugs. This 
research, aided by sophisticated brain imaging technology, has documented the surprising finding that the 
human brain is still maturing in significant ways during the adolescent years (49). The way the brain 
develops during adolescence may help explain why youth sometimes make decisions that seem to be quite 
risky. There are several lines of evidence suggesting that adolescents are uniquely susceptible to the short- 
and long-term effects of drugs. Early drug use may alter brain maturation, contribute to lasting cognitive 
impairment of certain functions, and significantly increase short- and long-term susceptibility for 
developing a substance use disorder (50). 
 
Research into brain development has shown that the maturing brain may be particularly vulnerable to the 
acute effects of drugs, and that drug use during adolescence may significantly increase a young person’s 
risk for developing a substance use disorder later in life (51). Nicotine is one substance that has been 
thought to make children more vulnerable to drug addiction in the future (52). While there are 
sociocultural influences, data at preclinical and clinical levels indicate that this adolescent sensitivity has 
strong neurobiological underpinnings. This may induce epigenetic changes that sensitize the brain to other 
drugs and prime it for future substance abuse (52-54) Cannabis use is another drug used in at risk 
adolescent populations. Cannabis use is associated with impairments of cognitive functions, including 
learning and memory, attention, and decision-making (55). A study was done by collecting and analyzing 
high-resolution MRI scans on young adult recreational marijuana user and non-using controls. Significant 
shape differences were detected in the left nucleus accumbens and right amygdala. The left nucleus 
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relationship across measures in the marijuana group. These data suggest that marijuana exposure, even in 
young recreational users, is associated with exposure-dependent alterations of the neural matrix of core 
reward structures and is consistent with animal studies of changes in dendritic arborization (55).  
Taken together, this data makes clear the significant public health implications for pediatric inhalant 
exposure and underscores the need for targeted efforts to reduce direct or indirect exposures to inhalants in 
children and adolescents. 
 
III.  Marketing / Advertising to Adolescents and Young Adults in social media age 
Research into exposure to pro-tobacco marketing and media has found an increase in the odds of youth 
holding positive attitudes toward tobacco use (odds ratio, 1.51; 95% confidence interval, 1.08-2.13) and 
more than doubles the odds of initiating tobacco use (odds ratio, 2.23; 95% confidence interval, 1.79-2.77). 
Highly engaging marketing and media are more effective at promoting use (odds ratio, 2.67; 95% 
confidence interval, 2.19-3.25). These effects are observed across time, in different countries, with 
different study designs and measures of exposure and outcome (56).  
 
According to United States Food and Drug Administration documents, marketing of e-cigarettes has been 
directed at the young adults and children (57). Sophisticated advertising and internet availability make 
electronic cigarettes easily accessible to youth. Electronic cigarette manufacturers advertise heavily 
through social networking systems and avoid using the word cigarette because of its negative connotations. 
Teenagers may deny using electronic cigarettes, but they state that they are vaping, for example, on a 
nicotine-containing, e-cigarette or flavored hookah pen. This may underestimate self-reported electronic 
cigarette or hookah use in surveys (7). Flavorings, which appeal to children, have been banned (except 
menthol) for combustible cigarettes, but not for electronic cigarettes. The various flavorings available for 
ENDS make them very attractive to young people. There are hundreds of electronic nicotine delivery 
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safety. In many places, the sales of electronic cigarettes are uncontrolled. Until the recent FDA rule they 
have not been licensed as drug or tobacco products or had regulation of ingredient labeling. This increases 
the odds that ingredients may vary with products and with different batches of the same product (7). The 
lack of child-proof containers for candy-flavored products poses a serious threat to young children. The 
availability of nicotine and advertised flavors allows anyone to make their own solutions at home.  
 
Increased marketing has contributed to the growing popularity of water-pipe smoking, higher overall sales, 
particularly through Internet sites, sponsorship at events, distribution of free samples, and direct 
advertisements (56, 58). Marketing techniques conceal potential dangers associated with water-pipes. For 
example, in the Eastern Mediterranean Region, the package is labeled as being “100% natural,” making the 
product seem more acceptable and perhaps even a healthy behavior to consider (59). Newer marketing 
strategies are focused on the portability of the hookah device with its carrying case and shoulder strap 
making the ease of transport seemingly more attractive (60). These same markets are advocating for the 
purchase of other products that claim to decrease the negative health effects of water-pipe smoking, such 
as filtered mouthpieces. None of these devices has been shown to be efficacious in reducing exposure to 
toxins or the associated risks of tobacco-related disease and death (60).  
 
IV.  Health Policy  
  In May 2016, the FDA published a final rule to extend its tobacco regulating authority to currently 
marketed products such as certain dissolvables, gels, hookah tobacco, electronic cigarettes, cigars, and 
pipe tobacco. Components and parts of tobacco products, but not their related accessories, are included 
in the scope of this rule (4). The rule restricts sales to minors younger than 18, requires health warnings 
on packaging, prohibits vending machine sales, and prohibits marketing the products as healthy or safe 
(4). These FDA rules do not address the use of candy and fruit flavors which appeal to youth and will 
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have already begun. In absence of strong federal regulation, states have been acting to restrict e-
cigarette purchases by minors, marketing targeted at children and adolescents, and the use of the devices 
in public places (61). 
  
V. Recommendations and Conclusions 
Professional groups with an interest in child health are actively engages on these issues. The American 
Academy of Pediatrics’ position is: 
1- Sales of e-cigarettes to minors younger than 18 years should be prohibited. 
2- Candy and fruit flavored e-cigarettes, which encourage youth smoking initiation, should be banned. 
3- Federal, state, and local governments should enact and enforce laws that mandate the provision of 
smoke-free environments, including e-cigarette vapor, in all public places and require employers to 
provide smoke-free/e-cigarette vapor-free work environments for their employees (61).  
The American Thoracic Society has a long-held position that e-cigarettes need to be subjected to the same 
marketing and manufacturing restrictions as tobacco products. The alarming increases in e-cigarette and 
hookah use in children, if left unchecked, will lead to another generation of young people becoming 
addicted to nicotine and will do tremendous and costly damage to the public’s health (62). 
Comprehensive tobacco control and prevention strategies for youth and young adults should 
address all tobacco products, including e-cigarettes. Further reductions in tobacco use and initiation 
among youth and young adults are achievable by regulating the manufacturing, distribution, marketing, 
and sales of all tobacco products—including e-cigarettes, and particularly to children—and 
combining those approaches with other proven strategies. These strategies include funding tobacco 
control programs at levels recommended by the Centers for Disease Control and Prevention (CDC); 
increasing prices of tobacco products; implementing and enforcing comprehensive smoke-free laws; and 
sustaining hard-hitting media campaigns, such as CDC’s Tips from Former Smokers that encourages 
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reducing the number of youth who move from experimenting to regular use.  
The rapid rise in e-cigarette and hookah use in school aged children should trigger a call to action in the 
medical and public health communities lest we repeat the mistakes made with cigarettes. Although the 
recent FDA final rule extending oversight to e-cigarettes and other ENDS and prohibiting sales to minors 
is an important step in the right direction it is only a start. We have more to do to help protect people 
worldwide from the dangers of tobacco and nicotine, especially our youth. As cigarette smoking among 
those under 18 has fallen, the use of other nicotine products, including e-cigarettes, has taken a drastic 
leap. The absence of effective regulations preventing aggressive marketing of nicotine products to children 
is creating a new generation of Americans who are at risk of nicotine addiction. 
 Better education and awareness of the dangers of inhalants to our youth and their parents are warranted. As it is 
clear that banning advertisements for cigarettes has led to decrease tobacco use in youth and adults, efforts to 
place similar restrictions on advertisement of e-cigarette and other inhalants must be pursued. Similarly, pricing/ 
taxation strategies to create financial barriers to youth using these products are worth consideration. Marketing 
strategies targeting children, including flavored products appealing to children must be banned. Investment in a 
comprehensive strategy for reducing the impact of ENDS and other inhaled substances on our children has the 
potential to deliver a significant public health return and prevent public health catastrophe. We can implement 
these cost-effective, evidence-based, life-saving strategies now. Together with additional effort and support, we 
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Figure1. Estimated percentage of high school students who currently use any tobacco products,* ≥2 tobacco 
products,† and select tobacco products§ — National Youth Tobacco Survey 2011–2015 
* Any tobacco product use is defined as past 30-day use of cigarettes, cigars, smokeless tobacco, e-cigarettes, 
hookahs, pipe tobacco, and/or bidis. 
† ≥2 tobacco product use is defined as past 30-day use of two or more of the following product types: cigarettes, 
cigars, smokeless tobacco, e-cigarettes, hookahs, pipe tobacco, and/or bidis. 
§ E-cigarettes and hookahs demonstrated a nonlinear increase (p<0.05). Cigarettes and smokeless tobacco 
demonstrated a linear decrease (p<0.05). Cigars, pipe tobacco, and bidis demonstrated a nonlinear 
Reproduced from Arrazola et al. (1) 
 
Figure2. Estimated percentage of middle school students who currently use any tobacco products,* ≥2 tobacco 
products,†,§ and select tobacco products¶ in the past 30 days — National Youth Tobacco Survey, 2011–2015 
* Any tobacco product use is defined as past 30-day use of cigarettes, cigars, smokeless tobacco, e-cigarettes, 
hookahs, pipe tobacco, and/or bidis. 
† ≥2 tobacco product use is defined as past 30-day use of two or more of the following product types: cigarettes, 
cigars, smokeless tobacco, e-cigarettes, hookahs, 
pipe tobacco, and/or bidis. 
§ ≥2 tobacco product use demonstrated a nonlinear change (p<0.05). 
¶ E-cigarettes and hookahs demonstrated a linear increase (p<0.05). Cigarettes, cigars, and smokeless tobacco 
demonstrated a linear decrease (p<0.05). Pipe tobacco 
and bidis demonstrated a nonlinear decrease (p<0.05). 
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